<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Cyberonics Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/cyberonics-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CYBX) Cyberonics Stops Generator Shipment</title>
		<link>http://www.stockbloghub.com/2011/08/16/cybx-cyberonics-stops-generator-shipment/81410</link>
		<comments>http://www.stockbloghub.com/2011/08/16/cybx-cyberonics-stops-generator-shipment/81410#comments</comments>
		<pubDate>Tue, 16 Aug 2011 16:58:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=81410</guid>
		<description><![CDATA[Recently, the leading neuromodulation company Cyberonics (CYBX) stopped shipment of two models of its Aspire platform generators. The company is currently retrieving the already sold but unused models namely No. 105 and 106.  The company has also suspended enrollment in its E-36 clinical trial pending resolution of this hardware related design issue. As a result of this massive set back, the company’s shares plunged more than 11% from the closing price of 12th August. The company’s decision is based on the realization that stimulation output current delivered to patients can be less than the output current programmed by a physician. The Vagus Nerve Stimulation (VNS) therapy System was approved for the treatment of medically refractory epilepsy in Europe in 1994 and in the US and Canada in 1997. Cyberonics is ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/16/cybx-cyberonics-stops-generator-shipment/81410/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CYBX) Cyberonics Stays Neutral</title>
		<link>http://www.stockbloghub.com/2011/07/11/cybx-cyberonics-stays-neutral/78605</link>
		<comments>http://www.stockbloghub.com/2011/07/11/cybx-cyberonics-stays-neutral/78605#comments</comments>
		<pubDate>Mon, 11 Jul 2011 15:54:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78605</guid>
		<description><![CDATA[We recently reiterated our Neutral recommendation on Cyberonics (CYBX) with a target price of $30.00, following our assessment of its fourth quarter 2011 results. Cyberonics reported fourth quarter 2011 EPS of 26 cents, which missed the Zacks Consensus Estimate of 29 cents and were well below the year-ago quarter adjusted EPS of 40 cents. The year-over-year decline was attributable to significant increase in income tax expense ($5.5 million in the reported quarter compared with the year-ago quarter level of $.03 million). Cyberonics develops and markets Vagus Nerve Stimulation (VNS) Therapy System, which is approved by the US Food and Drug Administration (FDA) for the treatment of refractory epilepsy and treatment-resistant depression (TRD). During the quarter, Cyberonics witnessed a continuous expansion in its top line, attributable to the company’s pioneer product, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/11/cybx-cyberonics-stays-neutral/78605/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook &#8211; April 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413</link>
		<comments>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413#comments</comments>
		<pubDate>Thu, 31 Mar 2011 23:07:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70413</guid>
		<description><![CDATA[Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory environment. Although a number of these issues remain, the industry is expected to fare better this year due to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest medical devices market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook December 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379</link>
		<comments>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379#comments</comments>
		<pubDate>Tue, 07 Dec 2010 01:15:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61379</guid>
		<description><![CDATA[Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, high unmet medical needs and increased incidence of lifestyle diseases (including cardiovascular diseases, diabetes, hypertension and obesity). Neuro, Orthopedic and Aesthetic represent the fastest growing categories. The aging population represents a major catalyst for demand of medical devices. The elderly population (persons 65 years and above) base in the U.S. registered 39.6 million in 2009, representing roughly 13% of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(STJ) St. Jude Medical Earns Japanese Approval for Neurostimulator</title>
		<link>http://www.stockbloghub.com/2010/10/03/stj-st-jude-medical-earns-japanese-approval-for-neurostimulator/53715</link>
		<comments>http://www.stockbloghub.com/2010/10/03/stj-st-jude-medical-earns-japanese-approval-for-neurostimulator/53715#comments</comments>
		<pubDate>Mon, 04 Oct 2010 05:12:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[Steelcase Inc.]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=53715</guid>
		<description><![CDATA[St. Jude Medical’s (STJ) Eon Mini spinal cord stimulation (SCS) system has been cleared by the Japanese Ministry of Health, Labor and Welfare (MHLW). The approval enables the Minnesota-based medical devices giant to market the device, claimed to be the world’s smallest, longest-lasting rechargeable neurostimulator, in Japan. Eon Mini is used for treating chronic pain of the trunk, back and/or limbs. The device delivers mild electrical impulses to the spinal cord that interrupt pain signal transmission to the brain, thereby offering relief. Eon Mini was approved for marketing in the U.S. and Europe in 2008. It is now the first rechargeable SCS to be approved for use in Japan. Chronic pain is a debilitating condition which is long lasting or recurring and affects roughly 50 million people in the U.S. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/03/stj-st-jude-medical-earns-japanese-approval-for-neurostimulator/53715/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243</link>
		<comments>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243#comments</comments>
		<pubDate>Wed, 25 Aug 2010 15:14:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WisdomTree SmallCap Dividend]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49243</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231</link>
		<comments>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231#comments</comments>
		<pubDate>Tue, 24 Aug 2010 22:53:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49231</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BSX) Boston Scientific Earns FDA Clearance on Spinal Cord Splitters</title>
		<link>http://www.stockbloghub.com/2010/06/27/bsx-boston-scientific-earns-fda-clearance-on-spinal-cord-splitters/41734</link>
		<comments>http://www.stockbloghub.com/2010/06/27/bsx-boston-scientific-earns-fda-clearance-on-spinal-cord-splitters/41734#comments</comments>
		<pubDate>Mon, 28 Jun 2010 04:23:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=41734</guid>
		<description><![CDATA[Boston Scientific’s (BSX) two spinal cord stimulation (SCS) lead splitters have been reportedly cleared by the FDA. The company will unveil the approved SCS splitters at the annual meeting of the American Society of Interventional Pain Physicians (ASIPP) being held from June 26 – 30, 2010, in Arlington, Virginia. The new lead splitters (W4 and D4) have been designed for use with Boston Scientific’s Precision Plus SCS System, the first-of-its-kind device for treating chronic pain of the trunk, back and/or limbs. Chronic pain is a debilitating condition that affects roughly 50 million people in the U.S. The annual cost associated with this condition has been estimated at $100 billion. Chronic pain, which is long lasting or recurring, is common in several back and spine conditions and is often misdiagnosed. Poor ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/06/27/bsx-boston-scientific-earns-fda-clearance-on-spinal-cord-splitters/41734/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CYBX) Cyberonics Beats Expectations &#8211; Raises Outlook</title>
		<link>http://www.stockbloghub.com/2009/11/20/cybx-cyberonics-beats-expectations-raises-outlook/21035</link>
		<comments>http://www.stockbloghub.com/2009/11/20/cybx-cyberonics-beats-expectations-raises-outlook/21035#comments</comments>
		<pubDate>Fri, 20 Nov 2009 23:49:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21035</guid>
		<description><![CDATA[Cyberonics, Inc. (CYBX) reported second quarter fiscal 2010 earnings per share of 32 cents, beating the Zacks Consensus Estimate of 20 cents and the year-ago earnings of 14 cents. Sales Net sales in the reported quarter increased 13.0% year over year to $40.7 million. Of this, net product sales in the domestic market increased 15.1% year over year to $33.5 million. Growth was due to higher average selling prices (ASPs) and sales volume. ASPs and sales volume increased 10.0% and 5.1% year over year, respectively. International sales increased 4.3% year over year to $6.8 million. Growth can be attributed to higher sales volume made through distributors, which was partly offset by lower ASPs. Licensing revenues constituted the remaining $0.4 million. Margins Gross margin increased 180 basis points (bps) year over ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/20/cybx-cyberonics-beats-expectations-raises-outlook/21035/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

